510(k) Report

510(k) · Cleared

Cleared

Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV Administration Sets, Q2 Extension Sets

K162304510(k) TraditionalCleared Dec 6, 2016111-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quest Medical, Inc. · FPA Set, Administration, Intravascular

Cleared on Dec 6, 2016 as substantially equivalent to K151079 (Quest Medical, Inc., 2015) and 2 other predicates after a 111-day review. Its family tree reaches back 3 generations to 2000.

Decided
Dec 6, 2016
Review
111 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
3

Its longest line of descent runs back 3 generations to K003225 (2000). 4 ancestors in all, the oldest K800825 (1980). No later device cites it as a predicate yet.

  1. Root · 3 generations backK003225 Solution Administration Sets with Capless Luer Activated ValveBaxter Healthcare Corp · 2000 · Recalled
  2. 2 generations backK040385 Multiport Manifold Set with Swabable Valves, Model 9900Quest Medical, Inc. · 2004
  3. 1 generation backK151079 Q2 Intravenous Adminstration Sets and Extension SetsQuest Medical, Inc. · 2015 · Recalled
  4. This deviceK162304 Q2 Multiport IV Administration Sets and Extension Sets, Checkmate…Quest Medical, Inc. · 2016
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K003225Solution Administration Sets with Capless Luer Activated ValveBaxter Healthcare Corp200018
−2K040385Multiport Manifold Set with Swabable Valves, Model 9900Quest Medical, Inc.2004—
−1K151079Q2 Intravenous Adminstration Sets and Extension SetsQuest Medical, Inc.20151
0 (this device)K162304Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV…Quest Medical, Inc.2016—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198010
FIG. 1 — Lineage of K162304, 2000–2016Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K151079Q2 Intravenous Adminstration Sets and Extension Sets
Summary page 4
…880.5440 CLASS: II PREDICATE DEVICES: Quest Medical, Inc. Q2 Multiport IV Administration Sets and Extension Sets (K151079, K800825) and CheckMate IV Administration Sets and Extension Sets (K040385) DESCRIPTION:…
Quest Medical, Inc.20151
*K800825Extension Set Quest Code #3000
Summary page 4
…0.5440 CLASS: II PREDICATE DEVICES: Quest Medical, Inc. Q2 Multiport IV Administration Sets and Extension Sets (K151079, K800825) and CheckMate IV Administration Sets and Extension Sets (K040385) DESCRIPTION: Sterile,…
Quest Medical, Inc.1980—
*K040385Multiport Manifold Set with Swabable Valves, Model 9900
Summary page 4
…IV Administration Sets and Extension Sets (K151079, K800825) and CheckMate IV Administration Sets and Extension Sets (K040385) DESCRIPTION: Sterile, single use non‐pyrogenic intravenous fluid administration sets wh…
Quest Medical, Inc.2004—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 2 companies; a new generation was cleared every 3.5 years on median.
  • 2 of the 4 ancestors have a recall of any class.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The Q2 and CheckMate Multiport IV Administration Sets and Extension Sets are indicated for use for the following:

For administration of intravenous fluids to a patient’s vascular system utilizing needleless components and an I.V. manifold for multiple simultaneous intravenous therapy via gravity, syringe, or infusion pump.

Use of a needle-free system may aid in the prevention of needle-stick injuries.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K162304: Q2 Multiport IV Administration Sets and Extension Sets, Checkmate Multiport IV Administration Sets, Q2 Extension Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162304

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026